Wednesday , October 18 2017
Home / Conditions (page 62)



Fatty Acids Can Be Marker for Type 2 Diabetes

High nonesterified fatty acids (NEFAs) show negative relationship to type 2 diabetes. But n-3 fatty acids (FAs) may protect against the disease… Chronically high nonesterified fatty acids (NEFAs) are a marker of metabolic dysfunction and likely increase risk of type 2 diabetes. By comparison, n-3 fatty acids (FAs) have been ...

Read More »

Practical Diabetes Care, 3rd Ed., Excerpt #4: Type 1 Diabetes: Insulin Treatment Part 1 of 2


David Levy, MD, FRCP Introduction Insulin treatment in type 1 diabetes is substitution/replacement hormone treatment, but replacement is much more variable and difficult to achieve than in other hormone deficiencies (e.g. thyroid, adrenal, gonadal hormones) because of the minute-by-minute variation in insulin secretion by the intact pancreas, which cannot yet be ...

Read More »

Effects of GIP and GLP-1 on Glucagon Response in Type 1 Diabetes

Glucose-dependent insulinotropic polypeptide and glucagon- like peptide-1 have glucose-dependent effects on glucagon secretion but differ in their effects on type 1 and type 2 diabetes patients… From various studies we know that glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) have glucose-dependent effects on glucagon secretion. GIP causes increased glucagon ...

Read More »

Deaf People at Higher Risk of Type 2 Diabetes

Inadequate access to primary care means that deaf people have a higher risk of developing type 2 diabetes, high blood pressure, and heart disease… The research, conducted at the School for Social and Community Medicine at the University of Bristol, compared the health of deaf people to that of people ...

Read More »